StockData
XTL Biopharmaceuticals Ltd logo

XTL Biopharmaceuticals Ltd (XTLB) stock

XTLBNasdaqPharmaceutical Preparations
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Jun 30, 2026Score 0/30
$1.54−0.08 (-4.94%)

Close on Nov 18, 2026Market cap $14.57MP/E –Yield –

XTL Biopharmaceuticals total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

XTL Biopharmaceuticals's total debt was $138.00K at Dec 31, 2024. For fiscal 2024 it was $138.00K.

Annual total debt

PeriodPeriod endValueChange
FY2024Dec 31, 2024$138.00K–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2024Dec 31, 2024$138.00K–
Q3 FY2024Oct 15, 2024$163.00K–

More XTL Biopharmaceuticals figures

See a number that looks wrong?